ClinicalTrials.gg
BiologicalDrug

Benralizumab clinical trials

Also written Fasenra and MEDI-563.

studies test it
67
open now
5
in phase 3
35
first study started
2006

How each study uses benralizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the benralizumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Nov 2017 · FASENRA · BLA 761070 (FDA, Drugs@FDA)
European Union
8 Jan 2018 · Fasenra · EMEA/H/C/004433 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Benralizumab
55
Benralizumab 100 mg
3
Benralizumab, Benra, Fasenra
3
Benralizumab 30 MG/ML [Fasenra]
2

Brand

Fasenra
12

Development codes

MEDI-563
7
KHK4563
1

Studies by the year they started

66 studies that test it; most in 2019 (8); 1 more planned to start later

Studies that test benralizumab, by start year
YearStudies
20061
20082
20091
20102
20111
20133
20143
20152
20166
20177
20186
20198
20207
20215
20222
20233
20243
20252
20262

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
19
Phase 3
35
Phase 4
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 46 · Other 21

AstraZeneca (38) · MedImmune LLC (6) · McMaster University (2) · Kyowa Kirin Co., Ltd. (2) · Aristotle University Of Thessaloniki (1) · Memorial Sloan Kettering Cancer Center (1) · Humanitas Clinical and Research Center (1) · NHS Greater Glasgow and Clyde (1)

Often tested with

Tested in the same studies.

Dupilumab (1) · Prednisolone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test benralizumab, phase 3 first.

Studies

Open first, then newest update. How each study uses benralizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 67

See all 67 studies that test benralizumab →

Given beside what is tested · 2 — benralizumab is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with benralizumab

Codes

What other systems call benralizumab · ClinicalTrials.gg INT006028

  • MeSH (NLM) C571386benralizumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 71492GE1FXBENRALIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1989100Confirmed FDA, Wikidata
  • Wikidata Q3638304benralizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C88594BenralizumabOne source FDA
  • DrugBank DB12023One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.